Altimmune (ALT) Non Operating Income (2010 - 2026)
Altimmune (ALT) recorded Non Operating Income of $3.4 million in Q2 2026, up 338.7% from $776,000 a year earlier and up 102.5% from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Non Operating Income (2010 - 2026) Analysis & Trends
On a TTM basis, Altimmune's Non Operating Income came in at $8.47 million as of Jun 30, 2026, up 42.4% year-over-year; for FY2025, it was $5.72 million, down 29.6% from FY2024.
- Annual Non Operating Income has a five-year compound annual growth rate of 76.1% (FY2020 to FY2025).
- Across earlier years, Non Operating Income came in at $8.11 million in FY2024 (+8.4%), $7.48 million in FY2023 (+164.4%), $2.83 million in FY2022 and -$176,000 in FY2021.
- The Q2 2026 figure is the highest quarterly Non Operating Income in data going back to Q2 2010.
- On a year-over-year basis, Non Operating Income rose in three of the last eight quarters, with growth averaging 27.9%.
- Peak year-over-year performance for Non Operating Income in the last five years was growth of 678.4% in Q2 2022, against a decline of 63.1% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.68 million (Q1 2026), $1.54 million (Q4 2025) and $1.85 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Altimmune | 556.20 Mn | 556.20 Mn | - | 3.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.40 Mn |
| Mar 31, 2026 | 1.68 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 776,000.00 |
| Mar 31, 2025 | 1.56 Mn |
| Dec 31, 2024 | 1.69 Mn |
| Sep 30, 2024 | 1.92 Mn |
| Jun 30, 2024 | 2.11 Mn |
| Mar 31, 2024 | 2.40 Mn |
| Dec 31, 2023 | 1.98 Mn |
| Sep 30, 2023 | 1.87 Mn |
| Jun 30, 2023 | 1.95 Mn |
| Mar 31, 2023 | 1.69 Mn |
| Dec 31, 2022 | 1.43 Mn |
| Sep 30, 2022 | 1.04 Mn |
| Jun 30, 2022 | 288,000.00 |
| Mar 31, 2022 | 69,000.00 |
| Dec 31, 2021 | 96,000.00 |
| Sep 30, 2021 | -306,000.00 |
API Access
Altimmune Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();